150 related articles for article (PubMed ID: 29674771)
21. High doses of dexamethasone in adult patients with idiopathic thrombocytopenic purpura.
Gutiérrez-Espíndola GR; Morales-Polanco MR; Guerrero-Rivera S; Talavera JO; Sánchez-Valle E; Gómez-Morales E; Pizzuto-Chávez J
Arch Med Res; 2003; 34(1):31-4. PubMed ID: 12604372
[TBL] [Abstract][Full Text] [Related]
22. [The impact of platelet membrane autoantibodies on high-dose dexamethasone therapy in patients with idiopathic thrombocytopenic purpura].
Wang R; Qin P; Ji XB; Hou M
Zhonghua Xue Ye Xue Za Zhi; 2009 Sep; 30(9):619-21. PubMed ID: 19954623
[TBL] [Abstract][Full Text] [Related]
23. Impact of Helicobacter pylori Eradication Therapy on Platelet Counts in Patients With Chronic Idiopathic Thrombocytopenic Purpura.
Amiri M
Glob J Health Sci; 2015 Nov; 8(7):35-40. PubMed ID: 26925898
[TBL] [Abstract][Full Text] [Related]
24. Short-course high-dose dexamethasone therapy for chronic idiopathic thrombocytopenic purpura in children.
Yadav D; Chandra J; Sharma S; Singh V
J Trop Pediatr; 2010 Dec; 56(6):446-7. PubMed ID: 20388659
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of Helicobacter pylori eradication in raising platelet count in adult patients with idiopathic thrombocytopenic purpura.
Veneri D; Franchini M; Gottardi M; D'Adda M; Ambrosetti A; Krampera M; Zanetti F; Pizzolo G
Haematologica; 2002 Nov; 87(11):1177-9. PubMed ID: 12414347
[TBL] [Abstract][Full Text] [Related]
26. Effects of a Helicobacter pylori eradication regimen on anti-platelet autoantibody response in infected and uninfected patients with idiopathic thrombocytopenic purpura.
Asahi A; Kuwana M; Suzuki H; Hibi T; Kawakami Y; Ikeda Y
Haematologica; 2006 Oct; 91(10):1436-7. PubMed ID: 16963398
[TBL] [Abstract][Full Text] [Related]
27. [Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura--the associateion between the activity of Helicobacter pylori and platelet recovery].
Sato K; Nagai T; Muroi K; Komatsu N; Ozawa K
Rinsho Ketsueki; 2004 Dec; 45(12):1252-4. PubMed ID: 15678917
[TBL] [Abstract][Full Text] [Related]
28. [Successful platelet recovery after the second eradication of Helicobacter pylori with metronidazole in two patients with chronic idiopathic thrombocytopenic purpura].
Takahashi T; Hatao K; Yamada K
Rinsho Ketsueki; 2006 May; 47(5):392-5. PubMed ID: 16784096
[TBL] [Abstract][Full Text] [Related]
29. Effect of high-dose dexamethasone in prednisone-resistant autoimmune thrombocytopenic purpura (ITP).
Dubbeld P; van der Heul C; Hillen HF
Neth J Med; 1991 Aug; 39(1-2):6-10. PubMed ID: 1961352
[TBL] [Abstract][Full Text] [Related]
30. High-dose cycles of dexamethasone in idiopathic thrombocytopenic purpura.
Calabresi AR; Veith RW; Rigby PG
J La State Med Soc; 2004; 156(5):269-72. PubMed ID: 15554097
[TBL] [Abstract][Full Text] [Related]
31. Helicobacter pylori infection in children with chronic idiopathic thrombocytopenic purpura.
Hamidieh AA; Arzanian MT; Gachkar L; Pasha F
J Pediatr Hematol Oncol; 2008 Jan; 30(1):96-7. PubMed ID: 18176194
[No Abstract] [Full Text] [Related]
32. Platelet and immune responses to oral cyclic dexamethasone therapy in childhood chronic immune thrombocytopenic purpura.
Kühne T; Freedman J; Semple JW; Doyle J; Butchart S; Blanchette VS
J Pediatr; 1997 Jan; 130(1):17-24. PubMed ID: 9003846
[TBL] [Abstract][Full Text] [Related]
33. [Short term high-dose dexamethasone therapy in previously untreated idiopathic thrombocytopenic purpura].
Li YF; Liu DS; Ding BH; Zhu JB; Chen BA
Zhonghua Nei Ke Za Zhi; 2009 Sep; 48(9):734-6. PubMed ID: 20079208
[TBL] [Abstract][Full Text] [Related]
34. Iron deficiency anemia successfully treated by Helicobacter pylori eradication in a patient with idiopathic thrombocytopenic purpura.
MORITA R; HASHINO S; OKADA K; TAKAHATA M; ONOZAWA M; KAHATA K; KONDO T; IMAMURA M; ASAKA M
Rinsho Ketsueki; 2009 Nov; 50(11):1655-7. PubMed ID: 20009444
[TBL] [Abstract][Full Text] [Related]
35. A multi-centre, single-arm, open-label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R-ITP1000 study).
Tran H; Brighton T; Grigg A; McRae S; Dixon J; Thurley D; Gandhi MK; Truman M; Marlton P; Catalano J
Br J Haematol; 2014 Oct; 167(2):243-51. PubMed ID: 25041261
[TBL] [Abstract][Full Text] [Related]
36. The role of Helicobacter pylori in children with chronic idiopathic thrombocytopenic purpura.
Bisogno G; Errigo G; Rossetti F; Sainati L; Pusiol A; Da Dalt L; Colleselli P; Grotto P; Carli M
J Pediatr Hematol Oncol; 2008 Jan; 30(1):53-7. PubMed ID: 18176181
[TBL] [Abstract][Full Text] [Related]
37. [Successful treatment of refractory idiopathic thrombocytopenic purpura by eradication of Helicobacter pylori].
Goto H; Kikuta T; Ota A; Tsuji H; Hino R
Rinsho Ketsueki; 2001 Dec; 42(12):1192-4. PubMed ID: 11828723
[TBL] [Abstract][Full Text] [Related]
38. Proof of an association between Helicobacter pylori and idiopathic thrombocytopenic purpura in Latin America.
Campuzano-Maya G
Helicobacter; 2007 Jun; 12(3):265-73. PubMed ID: 17493008
[TBL] [Abstract][Full Text] [Related]
39. Clinical characteristics and treatment outcomes in patients with Helicobacter pylori-positive chronic immune thrombocytopenic purpura.
Teawtrakul N; Sawadpanich K; Sirijerachai C; Chansung K; Wanitpongpun C
Platelets; 2014; 25(7):548-51. PubMed ID: 24176049
[TBL] [Abstract][Full Text] [Related]
40. Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura-a randomized controlled trial.
Suzuki T; Matsushima M; Masui A; Watanabe K; Takagi A; Ogawa Y; Shirai T; Mine T
Am J Gastroenterol; 2005 Jun; 100(6):1265-70. PubMed ID: 15929755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
